Lipopolysaccharide-induced inflammatory liver injury in mice

Laboratory Animals

Volumn 49, Issue , 2015, Pages 37-46

  Hamesch, k ^a   Borkham Kamphorst, E ^a   Strnad, P ^b   Weiskirchen, R ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

D galactosamine; hepatitis; inflammation; Lipocalin 2; SOP

Indexed keywords

LIPOPOLYSACCHARIDE;

ANIMAL; DISEASE MODEL; HEPATITIS; HUMAN; LABORATORY; MICROBIOLOGY; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; STANDARDS;

ANIMALS; DISEASE MODELS, ANIMAL; GUIDELINES AS TOPIC; HEPATITIS; HUMANS; LABORATORY ANIMAL SCIENCE; LIPOPOLYSACCHARIDES; MICE;

EID: 84952716317     PISSN: 00236772     EISSN: 17581117     Source Type: Journal    
DOI: 10.1177/0023677215570087     Document Type: Article

References (48)

1. Wolff A. Über Grundgesetze der Immunität. Zentralbl Bakteriol 1904; 37: 390–397.
2. Rietschel ET Kirikae T Schade FU. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994; 8: 217–225.
3. Schaedler RW Dubos RJ. Effects of cellular constituents of mycobacteria on the resistance of mice to heterologous infections. II. Enhancement of infection. J Exp Med 1957; 106: 719–726.
4. Ferluga J Allison AC. Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet 1978; 2: 610–611.
5. Galanos C Freudenberg MA Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 1979; 76: 5939–5943.
6. Quintero A Pedraza CA Siendones E. PGE1 protection against apoptosis induced by D-galactosamine is not related to the modulation of intracellular free radical production in primary culture of rat hepatocytes. Free Radic Res 2002; 36: 345–355.
7. Tuñón MJ Alvarez M Culebras JM González-Gallego J. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol 2009; 15: 3086–3098.
8. Ingawale DK Mandlik SK Naik SR. Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism(s): a critical discussion. Environ Toxicol Pharmacol 2014; 37: 118–133.
9. Josephs MD Bahjat FR Fukuzuka K. Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-α and not by Fas ligand. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1196–R1201.
10. Nowak M Gaines GC Rosenberg J. LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-α and the TNF-p55 receptor. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1202–R1209.
11. Bahjat FR Dharnidharka VR Fukuzuka K. Reduced susceptibility of nonobese diabetic mice to TNF-α and D-galactosamine-mediated hepatocellular apoptosis and lethality. J Immunol 2000; 165: 6559–6567.
12. Oberholzer A Oberholzer C Bahjat FR Edwards CK 3rd Moldawer LL. Genetic determinants of lipopolysaccharide and D-galactosamine-mediated hepatocellular apoptosis and lethality. J Endotoxin Res 2001; 7: 375–380.
13. Caroff M Karibian D. Structure of bacterial lipopolysaccharides. Carbohydr Res 2003; 338: 2431–2447.
14. Westphal 0 Lüideritz 0. Chemische erforschung von lipopolysacchariden Gram negative bakteriaen. Angew Chem 1954; 66: 407–417.
15. Burton AJ Carter HE. Purification and characterization of the lipid A component of the lipopolysaccharides from Escherichia coli. Biochemistry 1964; 3: 411–418.
16. Warren HS Fitting C Hoff E. Resilience to bacterial infection: difference between species could be due to proteins in serum. J Infect Dis 2010; 201: 223–232.
17. Reid RR Prodeus AP Khan W Hsu T Rosen FS Carroll MC. Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J Immunol 1997; 159: 970–975.
18. Boes M Prodeus AP Schmidt T Carroll MC Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 1998; 188: 2381–2386.
19. Beutler B Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003; 3: 169–176.
20. Gay NJ Symmons MF Gangloff M Bryant CE. Assembly and localization of toll-like receptor signalling complexes. Nat Rev Immunol 2014; 14: 546–558.
21. Bryant CE Symmons M Gay NJ. Toll-like receptor signalling through macromolecular protein complexes. Mol Immunol 2015; 63: 162–165.
22. Yang H Young DW Gusovsky F Chow JC. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J Biol Chem 2000; 275: 20861–20866.
23. González R Ferrín G Hidalgo AB. N-acetylcysteine, coenzyme Q10 and superoxide dismutase mimetic prevent mitochondrial cell dysfunction and cell death induced by D-galactosamine in primary culture of human hepatocytes. Chem Biol Interact 2009; 181: 95–106.
24. Lekić N Cerný D Hořínek A Provazník Z Martínek J Farghali H. Differential oxidative stress responses to D-galactosamine-lipopolysaccharide hepatotoxicity based on real time PCR analysis of selected oxidant/antioxidant and apoptotic gene expressions in rat. Physiol Res 2011; 60: 549–558.
25. Choi JH Kang JW Kim DW Sung YK Lee SM. Protective effects of Mg-CUD against D-galactosamine-induced hepatotoxicity in rats. Eur J Pharmacol 2011; 657: 138–143.
26. Nolan JP. The role of endotoxin in liver injury. Gastroenterology 1975; 69: 1346–1356.
27. Jirillo E Caccavo D Magrone T. The role of the liver in the response to LPS: experimental and clinical findings. J Endotoxin Res 2002; 8: 319–327.
28. Park BJ Lee YJ Lee HR. Chronic liver inflammation: clinical implications beyond alcoholic liver disease. World J Gastroenterol 2014; 20: 2168–2175.
29. Labbus K Henning M Borkham-Kamphorst E. Proteomic profiling in lipocalin 2 deficient mice under normal and inflammatory conditions. J Proteomics 2013; 78: 188–196.
30. Borkham-Kamphorst E van de Leur E Zimmermann HW. Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis. Biochim Biophys Acta 2013; 1832: 660–673.
31. McDonald B Jenne CN Zhuo L Kimata K Kubes P. Kupffer cells and activation of endothelial TLR4 coordinate neutrophil adhesion within liver sinusoids during endotoxemia. Am J Physiol Gastrointest Liver Physiol 2013; 305: G797–G806.
32. Gulle K Akpolat M Kurcer Z Cengiz MI Baba F Acikgoz S. Multi-organ injuries caused by lipopolysaccharide-induced periodontal inflammation in rats: role of melatonin. J Periodontal Res 2014; 49: 736–741.
33. Hooijmans CR Leenaars M Ritskes-Hoitinga M. A gold standard publication checklist to improve the quality of animal studies, to fully integrate the three Rs, and to make systematic reviews more feasible. Altern Lab Anim 2010; 38: 167–182.
34. Liedtke C Luedde T Sauerbruch T. Experimental liver fibrosis research: update on animal models, legal issues and translational aspects. Fibrogenesis Tissue Repair 2013; 6: 19–19.
35. Walkin L Herrick SE Summers A. The role of mouse strain differences in the susceptibility to fibrosis: a systematic review. Fibrogenesis Tissue Repair 2013; 6: 18–18.
36. Popov Y Schuppan D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 2009; 50: 1294–1306.
37. Zhu X He L McCluskey LP. Ingestion of bacterial lipopolysaccharide inhibits peripheral taste responses to sucrose in mice. Neuroscience 2014; 258: 47–61.
38. Russell WMS Burch R. The principles of humane experimental technique, London: Methuen, 1959.
39. Rudaya AY Steiner AA Robbins JR Dragic AS Romanovsky AA. Thermoregulatory responses to lipopolysaccharide in the mouse: dependence on the dose and ambient temperature. Am J Physiol Regul Integr Comp Physiol 2005; 289: R1244–R1252.
40. Giebeler A Streetz KL Soehnlein O Neumann U Wang JM Brandenburg LO. Deficiency of formyl peptide receptor 1 and 2 is associated with increased inflammation and enhanced liver injury after LPS-stimulation. PLoS One 2014; 9: e100522–e100522.
41. Koo HJ Yoon WJ Sohn EH. The analgesic and anti-inflammatory effects of Litsea japonica fruit are mediated via suppression of NF-κB and JNK/p38 MAPK activation. Int Immunopharmacol 2014; 22: 84–97.
42. Morioka S Broglie P Omori E. TAK1 kinase switches cell fate from apoptosis to necrosis following TNF stimulation. J Cell Biol 2014; 204: 607–623.
43. Boaru SG Borkham-Kamphorst E Tihaa L Haas U Weiskirchen R. Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease. J Inflamm (Lond) 2012; 9: 49–49.
44. Kim YH Yoon DW Kim JH Lee JH Lim CH. Effect of remote ischemic post-conditioning on systemic inflammatory response and survival rate in lipopolysaccharide-induced systemic inflammation model. J Inflamm (Lond) 2014; 11: 16–16.
45. Hoque R Farooq A Ghani A Gorelick F Mehal WZ. Lactate reduces liver and pancreatic injury in toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity. Gastroenterology 2014; 146: 1763–1774.
46. Wu YH Hu SQ Liu J. Nature and mechanisms of hepatocyte apoptosis induced by D-galactosamine/lipopolysaccharide challenge in mice. Int J Mol Med 2014; 33: 1498–1506.
47. Carson M. Ribbons. Methods Enzymol 1997; 277: 493–505.
48. Ferguson AD Hofmann E Coulton JW Diederichs K Welte W. Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science 1998; 282: 2215–2220.